PUNE, India, March 17, 2017 /PRNewswire/ --
According to a new market research report "Blood Flow Measurement Devices Market by Product (Ultrasound (Transit Time Flow Meter), Laser Doppler), Application (Invasive (CABG, Microvascular Surgery), Non-invasive (Cardiovascular, Gastroenterology & Tumor Monitoring)) - Global Forecast to 2021" published by MarketsandMarkets, the market is expected to reach USD 533.0 Million by 2021 from USD 343.6 Million in 2016, growing at a CAGR of 9.2%.
Browse 70 market data Tables and 42 Figures spread through 126 Pages and in-depth TOC on "Blood Flow Measurement Devices Market"
Early buyers will receive 10% customization on this report.
This report analyzes and studies the major market drivers, restraints/challenges, and opportunities for the forecast period of 2016 to 2021. The global Blood Flow Measurement Devices Market is segmented on the basis of product, application, and region.
Based on product, the Blood Flow Measurement Devices Market is categorized into ultrasound and laser Doppler. In 2016, the ultrasound segment commanded the largest share of the global blood flow measurement device market. This growth can be attributed to the growing applications of ultrasound products, such as vascular diseases and dermatology, and their usability in invasive as well as non-invasive applications. The ultrasound market is further categorized into ultrasound Doppler and transit-time flow meters (TTFM). In 2016, the ultrasound Doppler segment commanded the largest share of the global ultrasound market. The large share and high growth rate of these devices can be attributed to their growing applications, ease of use, and increased preference for non-invasive devices.
Ask for PDF Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=243081818
Based on application, the Blood Flow Measurement Devices Market is segmented into non-invasive applications and invasive applications. Non-invasive applications are further categorized into cardiovascular disease, diabetes, tumor monitoring, gastroenterology, and others applications (dermatology and intracranial pressure monitoring). The cardiovascular disease segment commanded the largest share of the global blood flow measurement device market, by non-invasive applications, in 2016. The large share and high growth rate of this segment can be attributed to the increasing prevalence of cardiovascular disease, rising geriatric population, and increasing focus of key market players on this market.
Similarly, invasive applications are further segmented into coronary arterial bypass graft (CABG), microvascular surgery, and others (organ transplants and reconstructive surgery). The CABG segment commanded the largest share of the global Blood Flow Measurement Devices Market in 2016. The growth in this segment can be attributed to a large number of CABG surgeries performed worldwide.
Speak to Our Experts @ http://www.marketsandmarkets.com/speaktoanalyst.asp?id=243081818
The key players in the Blood Flow Measurement Devices Market include Cook Medical, Inc. (U.S.), Medistim ASA (Norway), Transonic Systems, Inc. (U.S.), ADInstruments (Australia), Moor Instruments Ltd. (U.K.), Deltex Medical Group plc (U.K.), BIOPAC Systems, Inc. (U.S.), Atys Medical (France), Compumedics Ltd. (Australia), Perimed AB (Sweden), and SONOTEC Ultraschallsensorik Halle GmbH (Germany).
Browse Related Reports:
Interventional Cardiology & Peripheral Vascular Devices Market by Type (Angioplasty Balloon, Stent, Catheters, EVAR Stent Grafts, Abdominal Aortic Aneurysm, IVC Filter, Plaque Modification, Hemodynamic Flow Alteration, Accessories, Guidewire) - Forecasts to 2021
Hemodynamic Monitoring Systems Market by Product (Systems, & Disposables), Type (Invasive, Minimally invasive, & Non-invasive), End User (Hospitals, Cath labs, & Home and Ambulatory Care) - Global Forecasts to 2021
MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/medical-devices
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets